Clinical Trial Update: Mouse Allergen and Asthma Intervention Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a mouse allergen exposure intervention for asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Johns Hopkins University | Conditions: Asthma, Mouse Allergy | Phase 3 | Status: COMPLETED